Renal Arterial Resistive Index for Differential Diagnosis of Acute Kidney Injury
Value of Renal Resistive Arterial Index for Differential Diagnosis of Patient With Anticipated Acute Kidney Injury Administered to Emergency Department
1 other identifier
observational
30
1 country
1
Brief Summary
early differential diagnosis of anticipated acute kidney injury via ultrasound renal resistive index calculation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2022
CompletedFirst Submitted
Initial submission to the registry
June 4, 2022
CompletedFirst Posted
Study publicly available on registry
June 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2022
CompletedJune 8, 2022
June 1, 2022
6 months
June 4, 2022
June 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
increased resistive index
differential diagnosis of acute kidney injury using renal doppler ultrasound and resistive index and comparison of subgroups
time spent at emergency service until renal doppler is done and resisitive index is calculated (6 hours)
Secondary Outcomes (2)
mortality
mortality at 7 days
mortality
mortality at 28 days
Eligibility Criteria
patient administering to emergency service with acute kidney injury independent of etiology
You may qualify if:
- age over 18
- patient with acute kidney injury diagnosed according to KDIGO, AKIN or RIFLE criteria
You may not qualify if:
- end stage kidney disease
- patients receiving renal replacement treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diskapi Research and Training Hospital
Ankara, 06110, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- asossicated professor
Study Record Dates
First Submitted
June 4, 2022
First Posted
June 8, 2022
Study Start
May 10, 2022
Primary Completion
November 10, 2022
Study Completion
November 10, 2022
Last Updated
June 8, 2022
Record last verified: 2022-06